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Coronary Artery Disëase 
Numerous attempts have been made to demonstrate 
a causal relationship between hypercholesterolaemia 
and atherosclerosis; but no such relationship has 
been clearly shown to exist although, equally, it 
has not been disproved. 
Evidence yielded by a frontal attach - 
comparison of tl plasma cholesterol levels in 
persons rith and without clinical evidence of 
atherosclerosis - is inconclusive. 
Acute CoronárT Infarct ion. In a well controlled 
experiment r,!'jassnikow (1924) stated that out of 26 
patients, 14 who suffered from Angina Pectoris had 
elevated serum cholesterol, the values ranging from 
190 - 440 mgr, whereas in twenty five healthy persons 
the serum cholesterol ranged from 120 - 170 ri . 
Mjassnikow only mentioned the term "angina pectoris', 
so that his group of cases were presumably not 
suffering from coronary infarction in the acute 
sta..;e; nor is it clear whether these patints had 
previously suffered from acute myocardial infarction. 
The results in norr:?al subjects stated by hir were 
very low compared with those of most workers, so the 
question of technique may arise. 
Similarly clear differences have been found by , 
others, but this is not the general experience. A 
considerable overlap is a more usual finding. / 
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. Thus Davis, Stern and Lesnick (1937) studied 
blood lipids and cholesterol in 59 patients with 
angina pectoris and in 54 controls using two 
different analytical methods which gave concordant 
results. They found that there was considerable 
overlapping of serum cholesterol values in the two 
groups and that the difference was not statistically 
si c;nif icant, alt hough a a'all group (2C) of those 
with angina pectoris showed values well above the 
highest normal value. They also found high values 
for the free fraction of th : serum cholesterol. 
Their pati-mts were not in the acute stage of 
coronary infarction at the time of the examination 
but appro i_mately one third of the group gave a 
history consistent with cardiac infarction in the 
past. This group of cases was not separated from 
the others, the results being published as a whole 
so that definite conclusion cannot be reached as to 
the relative importance of acute coronary infarction 
and angina pectoris. . They diagnosed the incidence 
of infarction from the history only, and in the 
absence of E.C.G. confirmation, their diagnosis of 
infarction cannot be accepted as absolutely definite. 
These workers also shoved the free fraction of the 
plasma cholesterol to be increased in angina pectoris 
Similarly stiddii and n6mánski(1943) using an 
adaptation of Bloor's (1916) method, and studying/ 
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serum cholesterol in patients ':pith coronary 
arterio- sclerosis found that these patients had 
serum cholesterol levels significantly higher than 
in normal subject. They further observed that 
the serum cholesterol level fluctuated in their 
cases of coronary arte rio- sclerosis . Fifteen 
cases were studied of whom 13 had coronary 
occlusion confirmed by electrocardiography. The 
measurements of serum cholesterol were made about 
6 v!ee_r.s after the acute attack.- The remaining 
two patients had angina pectoris without evidence 
of infarction. These -..or'.ers examined B.M.R. 
and tested :or Urine sugar in each patient to 
e cclude myxoedema. or diabetes as causes of hyper - 
cholesterolaemia. The average serum cholesterol' 
for individuals ran,g,ed from 296 r.lg - - 499 mg» with 
a general average for the 7;;hole series of 355 mg; ; 
the maximum cholesterol level was 499 mg» in a patier 
aged 72 years and the next highest .was 3 ";9 mg;; in 
one aged 69 years. :`any observers, however, have 
now shown that higher levels of cholesterol are 
usually found in youn ger patients rather than older 
so that othkr:r factors may be involved in these cases. 
It may be that the very high results which Steiner 
and Dana nski obtained are due to the use of Bloor's 
method, :ehich usually gives higher results than more 
recent procedures. Their figures for normal/ 
t 
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controls were also high - mean 255 with a 
maximum of : 34 mg:, , and a minimum of 214 mg; , - so 
that their general conclusion is valid. 
That age may, be a factor in the hypercholestero - 
aemic tendency was pointed out by Learman and .:bite 
(1946) , who, ho ever, were studying patients with 
angina pectoris but ithout acute coronary infarctio 
However, the same observation has been reported by 
others in acute coronary infarction. 'Morrison, 
Hall and Chaney (1948) studied 200 cases of coronary 
roacluatam within 48 hours after hospital admission 
using Sperry's digitoni l -. ethod of deter,aiaation. 
They concluded that eoronry thrombosis in patients 
under the age of 60 is frequently associated with 
hyperchole sterolaem is and disturbances of cholestero 
metabolism, on the grounds that (a) . 68ïß of 75 
patients under 60 years of age with proved acute 
coronary occlusion had hyr:ercholesterolaemia, 
(b) 52 of 125 cases over 60 years of age with 
proved acute coronary occlusion showed a cholesterol 
level within the normal range, only 48,= showing 
hywercholesterolaer:_ia. In these cases, incidentally 
the average percentage of the cholesterol in the 
free state was 30i compared with 28`,- in the normal 
controls. Morrison et :al further concluded that 
high plasma cholesterol valu s may be an etiological 
factor in many cases of coronary occlusion but that/ 
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other cases occur in :hich it would appear that 
cholesterol re taboli sm may not be involved. A 
similar tendency was noted by Cohen (1949) and 
by Geier (1949) ; this last author states that 
whereas none of 16 healthy subjects had a plasma 
chole sterol. c oncentration exceeding 300 mg. per 
100 ml. , this level was exceeded by 43-, of patients 
with coronary artery disease and under 55 years old, 
but by 16, of similar patients over 55 years old. 
These results, which for' , a fair cross section 
of those reported in the literature show that 
hype rchole sterolceinia, in the sense of a plasma 
chòlesterol concentration distinctly above the 
normal max inL :, u. es not necessarily precede 
coronary artery disease. lov:evEr, the normal range 
is so : ide that the L i;-;ure found in Patient 
coronary arterio sclero si s nay e11 represent a 
personal hypercholesterolaeuia - i.e. above that 
previously cus tomary for the individual concerned. 
It is, however, striking that such tendency to 
hyperchole ste rolae:ii a (in the gene ral sense ) as 
exists is greater in the youner IDotients. 
His examination of normal, 
atheroCnatous, and sclerotic orteries shows that 
deposition of cholesterol in the vessel walls is an 
important part of the disease process (Virchow, 1924) 
Aschoff (1924), Leary (19 -14)_. A similar/ 
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conclusion is given by the animal experiments of 
Anitschkow (1933) , -Leary (1941), Weinhouse and 
Hirsch (1940) , "i: ukhe j ee (1946 -1947) and others. 
However, although it would appear that hypercholest 
aemia may aid abnormal deposition of cholesterol in 
vessel walls, it has not been shown to be do 
essential factor, and, indeed, Duff (1935) claimed 
to have observed that injury to the vessels seemed 
to precede the deposition of cholesterol. 
On the whole, it appears likely, as Peters and 
Van Slye (l'_E) suggest, that "choles'er accumulate 
in the walls of The arteries when these are 
affected by degenerative processes or suffer local 
injuries'}. Such a deposition might be aided by 
hypercholesterolae iia or, Without actual elevation 
of the plasma. cholesterol level, by a decreased 
stability in solution either of the cholesterol 
alone or of the colloidal solutes in general 
(Alvarez and Neuschlosz, (1931); Eck and Desbordes 
(1934); Hueper (1944) etc.). It is particularly 
significant that Eck and Desbordes (1935) foufld the 
stability of the plasma cholest: rol to decrease with 
advancing age; this suggests that deposition might 
tend to occur at a lower plasma cholesterol 
concentration in old than in younger persons. 
Angina Pectoris. Although some of the reports 
considered in the p_eceding section certainly 
included data from .,patients without acute coronary/ 
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infarction, the majority dealt clearly '`iith that 
condition. It is, however, important to enquire 
w he the r the tendency to hyperchole sterolaem is is 
confined to acute coronary infarction or is found 
in of her stages of coronary di sea se This may 
well have a considerable bearing on the -_ zestion 
of whe ther disturbance of . the : plasma chole stero 
precedes ( -and may therefore be a cause of) coronary 
artery damage or whether the latter is the earlier 
phenomenon. 
Bachmei seer and Tens (1913) , from a study of 
13 cases of angina .pectoris 1ith arteriosclerosi s, 
concluded that patients w ith arteriosclerosis in 
this stage of development shoved an increase in 
blood cholesterol. It is true that the method 
avai lable for estimation of chole sterol was far 
from perfect at that time, as is agreed by many 
observers, and that Bloor t s me t "b.od as then used, 
gave very high results. Further, the authors 
failed to mention the etiology of the arter_ioscleroti 
changes. Another difficulty is that these early 
workers used whole blood as their analytical 
material. Her ce their observation of high blood 
cholesterol cannot be accepted as definitive. 
In the same year eltman (1913) also reported that 
11 out of 12 persons with angina pectoris and 
arteriosclerosis had increased blood cholesterol/ 
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but his observations too were open to objection. 
Similar findings were reported by other workers. 
Thus Denis (1917) found that 5 out of 14 patients 
with angina pectoris and arteriosclerosis had values 
for blood cholesterol exceeding those of 20 control 
persons; Gorham and Layers (1917) reported that 
the range of cholesterol levels in 10 patients 
exceeded that in 14 norrlal persons.íajassnikow 
(1924) stated that out of 16 patients, 14 suffering 
from angina pectoris had a high serum cholesterol. 
Here he only mentioned the angina pectoris group of 
cases as such and did not give their history. The 
range which he gave - 190 - 440 ,,,r per 100 nil. serum 
is contrasted ::ith his rather surprising normal 
range of 120 - 170 mg which :.as much lower than 
is nowadays generally accepted. Stepp (1918) 
failed to demonstrate elevation of the cholesterol 
content of serum and his ,.;or'_ is noteworthy because 
at that period, as has-ben mentioned, most other 
observers found high cholesterol levels in angina 
pectoris. The reason may be that Stepp selected 
only these cases of angina pectoris without any 
other obvious cause for hypercholesterolaemia. In 
more recent times with improved analytical methods, 
Andes, Kamprneir and Adaìls (1936) could not find a 
high cholesterol level in angina using an 
adaptation of the method of Lyers and 'Wardell. / 
-9 -. 
Page, Kirke and Van Slyke (1936) also failed to 
find high concentrations of plasma cholesterol . 
possibly again because they employed an accurate 
gasometric method and diagnosed the cases accurately 
as angina pectoris '.'i th essential hypertension. 
Elliot and Nuzum (1936) using, however, hole 
blood by a modified ;loon's method also failed to 
get...high results such as the hole..blood sai.ples 
had usually given in the hands of earlier workers. 
These later results 'strongly support the 
view that the plasma cholesterol level is not 
increased, at least regularly, but these observers 
failed to classify the cases according to duration, 
which Ina v oil be an important factor. In contrast 
to these wholly positive or ~wholly negative results, 
Davis, Stern, Lesnick (1937) published a 
comparative study of colorimetric and gravimetric 
determinations of blood lipids and cholesterol. 
Their material included 59 cases ,.kith angina pectori 
and 54 norml controls they found that there was 
a considerable overlapping of serum cholesterol 
values in the two groups and that the differences 
were not statistically significant, but a small 
group of (20;3') of those with angina pectoris showed 
values well above the highest normal value. 
Evidently the position pith respect to the plasma 
cholesterol in angina pectoris without acute coronar 
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infarction is obscure. Clarification is essential 
if concl-asions are to be reached as to the existence 
of hypercholesterolaemia as a regular feature of 
arterial degeneration as distinct from a special 
feature (whether cause or effect) of coronary occlusion. 
Hypertension. The level of the plasma cholesterol 
appears to be related to vascular degenerative change 
in general rather than to coronary disease in 
particular. This is important in itself but does not 
decide whether the cholesterol abnormality which 
frequently,_ though not invariably, accompanies 
coronary disease is a precursor of or a sequel to the 
vascular disease. 
The relation of the serum cno1 s cal ì 6k 
hypertension seems to have first been studied by 
Ie Moine (1911) , who, using a semi-quantitative colour 
test, found the cholesterol content of the serum 
abnormally high in clinical hypertension. Pribrara 
and Klein (1924) measured the plasma cholesterol in 
47 cases of hypertension, and reported that 76 of 
their cases showed high values. Westphal (1924 -1925) 
Gelman (1927), Wacker and Fahrig (1932) and Medvei 
(1932) have reported similar results. i ;yore recently 
Davis, Stern, Lesnick (1937) found high cholesterol 
content of blood in hypertension with arterio sclerosis/ 
as did Steiner and Domanski (19áe) . On the other 
hand Loewenstein (1928) reported 50 cases of 
hypertension of which 4 were apparently nephritic 
and the rest were cases of essential hypertension. 
Of the 50, he found that only one had serum total 
cholesterol above 180 mg's- which he considered the 
maximum normal value by his calorimetric method. 
Harris (1930) also reported normal total cholesterol 
levels in hypertension whilst Weinstein and. Weiss 
(1931) found a high total cholesterol in only 5 of the 
37 cases of uncomplicated essential hypertension. 
Alvarez and ldeuschlosz observed normal total cholesterol 
in hypertension; they, however, studied also the 
ability of the serum-to dissolve additional free 
cholesterol and found that the sera of 21 out of 25 
hypertension cases appeared to be saturated with 
cholesterol whereas most normal sera dissolved added 
cholesterol. 
Kirchgessner (1934) reported that most 
hypertensive subjects in a series of 49 showed high 
values for free cholesterol although the total 
cholesterol was normal.- Bthger and Mobilus (1934) 
observed that both free and total cholesterol were 
normal in hypertension. 
Gibbs, Buc ner & -Moor (1933) found that the 
group of diabetics e i th the most advanced clerosis 
showed the highest total and esterified cholesterol/ 
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contents an d that in these the proportion of 
cholesterol in ester if ied form was 10 -15`,:d above the 
usual normal value. 
Diabetes in general is associated with some - 
degree of hypercholesterolaemia but it is noteworthy 
that this is apparently intensified as vascular 
degeneration increases. For example Page, Kirk and 
Van Slyke (1936) determined the plasma cholesterol by 
gasometric method in 16 pati,en ts, diagnosed as 
essential hypertension, definitely and by proper 
investigation; data from 2 patients ; ith malignant 
hyper ten sion were also ob tai n 3d; yet they detected no 
regular increase either in plasma lipids generally, 
nor in the free and total cholesterol ratio. Similarly 
Peters and Yen (1943) failed to observe any high 
cholesterol neutral fat or lipoid phosphorus level of 
plasma in hypertension. 
Calculation from the data of Page et al (1936) 
yields the noteworthy result that in their series of 
hypert.:nsives the free cholesterol formed, on the 
average, 37= of the to tal plasma cholesterol, a 
considerable increase above the normal 27f ;. This ,is 
a finding of importance in relation to the view, which 
will be developed later in this thesis, that vascular 
degeneration leads slowly to deficient liver function/ 
-13, 
and Therefore to an excessive proportion of free 
cholesterol in the plasma. 
It is evident that There is no more unanimity 
concerning the relation of hypertension than 
concerning that of coronary disease to the plasma 
cholesterol level. Nevertheless the evidence, taken 
in toto suggests that hypertension tends to be 
associated with some degree of hypercholesterolaemia 
involving principally, the free cholesterol. It may 
be that factors such as age of the patient, duration 
of the hypertension etc. , have been insuffic iently 
taken into account and that they may play an important 
role. Their influence wi 11 be considered in the 
experimental part of this thesis. 
Congestive Cardiac Failure. Little attention seems 
to have been paid to Ipstein's (1936) observation 
that in a short series of cases of congestive heart 
failure the total plasma cholesterol tended to be low 
although the free cholesterol was either normal or 
actually high. Yet this is an observation of 
considerable importance, for it has repeatedly been 
observed that in this condition the liver is fre uently 
enlarged and that liver function tests sometimes at 
least give abnormal results. The findings in relation 
to hepatic function were well reviewed by Cantarrow 
(1935) and later work has emphasised the tendency to/ 
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disturbed liver ftinction dur ing acute congestive 
heart failure with some recovery. of function vrhen 
the cardiac condition improves. It is obvious that 
further observations of the plas a cholesterol in 
this condition are required and , if considered in 
relation to the liver functional efficiency and to 
vascular degeneration, may nrov i de useful information. 
-15- 
EX FEßIN1 ENT PART 
1:113TIrO DS 
Total cholesterol was determined in plasma 
separated from oxalated venous blood withdrawn (in 
the case of the hospital patients) at 10 - it a.m., 
about three hours after breakfast. The method used 
was that of Sackett (1925) adapted for use with a 
Spekker absorptiometer. 
Free cholesterol was determined in the same 
plasma samples by Clark's (1945) modification of 
the digitonin precipitation method described by 
Sperry (1936). 
This combination of methods was chosen as being 
more convenient than using the digitonin method 
before and after hydrolysis. That it is reliable 
is indicated by the fact that the ratio of free to 
total cholesterol obtained by its use agrees well 
with the ratio reported by other methods. 
Total Cholesterol 
The determination of the total cholesterol of 
plasma has been based on the method of Sackett (1925) . 
0.2 ml. of pia s a is pipetted drop by drop in a 
centrifuge tube containing a mixture of 9.0 ml. of 
absolute alcohol and 3.0 ml. of ether. The tube 
is closed by a dry stop ;,er, is sha en vigorously 
for about one minute and is then alloyed to lie 
horizontally with an :ven distribution of the/ 
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precipitate along the tube for 30 minutes. The 
mixture is then cen tri fu ged and the supernatant 
liquid poured as completely as possible into a 
small beaker. This is placed on a hot plate and 
the contents carefully eva-:orated to dryness. 
The residue is extracted with 1 cc. chloroform - 
four times into a 10 ml. measuring cylinder and the 
volume made to 5 ml. with chloroform. To the 
5 inl. extract, 2 Ill. of 'acetic- anh; Bride and 0.1 ial. 
of concentrated sulphuric acid are added. The 
cylinder is stoppered and its contents mixed and 
after standing in a dark place for 10 minutes, the 
colour is then read in a Spekker absorptiometer 
against ': ater. The cholesterol equivalent is 
obtained from a calibration curve prepared for the 
purpose. 
Free Cholesterol 
Free chole sterol was determined by a slightly 
modified form of Clark's adaptation (1945) of the 
digitonin precipitation method of Sperry (1934) . 
Extraction of plasma; for each 1.0 ml. of plasma 
about 20 ml. of ace tone -alcohol (1:1) are placed 
in a 25 ml. volumetric flask and the plasma 
pipetted into this drop by drop with constant 
shaking. Additional acetone- alcohol is added to 
just be low the calibration mark on each flask and 
extraction allowed to take place overnight at room/ 
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temperature. The unfiltered extracts are. quite 
stable and may be kept for some days if necessary. 
After extraction,-the flas s are made up to volume 
and contents _well mixed and filtered through lipid - 
free filter paper. 'Evaporation is avoided by 
keeping the funnels covered and v ;orking rapidly.. 
Precipitation of Free Cholesterol. Of each 
filtrate 10 ml. are .pipetted into 30 m1. conical 
centrifuge tubes, d ml. of the digitonin solution 
(0.4 g. digitonin in 100 ml. of a 500 (V /V) 
solution of ethyl alcohol in water) added to each 
and the miyture stirred well. The rods are left 
in the tubes which are placed in one or more covered 
Mason Jars containing a layer of sand and left 
overnight at room temperature. The rods are then 
removed to a numbered rack after, both the rods and 
the walls of the tubes have been washed down with 
acetone to free the precipitates. Care must be 
taken to return each rod to the correct tube -in order 
to avoid the loss of any precipitate which may have 
adhered to it. The tubes are then centrifuged for 
30 minutes at high speed, after which the supernatant 
fluid is poured off carefully. Centrifuging in 
this way allows the supernatant fluid to be poured 
off without disturbing the precipitate and avoids 
the suction rae trod used by Clarke. At this stage 
the tubes .may, if necessary, be left for some time/ 
if kept covered in Eason Jars. The stirring rods 
are replaced in the tubes, the rods and the tube 
walls are washed with 4 ml. of acetone -ether (1:2). 
The ether used must be free from peroxide. After 
thorough stirring the rods are ranoved and washed 
down with a small amount of acetone-ether. The 
tubes are again centrifuged at high speed for ten 
minutes, the supernatant fluid is removed as before, 
and this washing is repeated two or more times now, 
however, with pure ether (peroxide free) . After 
the final washing, tubes are kept horizontally at 
room temperature for half an hour, incubation at 
40 0C as described by Clarke having been found to be 
unnecessary. Hhen the precipitates are dry the rods 
are put back in to the Original tubes. 
Develo ment and reading of color. The tubes are 
then placed in Ù bath (a deep sand -bath is 
convenu. nt) whose temperature has been adjusted to 
exactly 110 °C, .;here they remain for half an hour. 
To each tube 2 ml. of glacial acetic acid are added 
and stirred with the rod, after which the tube is 
replaced in the same sand -bath for one minute. The 
precipitate dissolves completely and Clarke's 
further incubation at 60 °C is not necessary. The 
tubes ere then transferred to a water bath at 25 °C. 
While the temperature equilibrium is being attained 
a fresh mixture of acetic anhydride sulphuric acid/ 
-1:- 
is made up in proportions, 20 volumes of.acetic 
anhydride to 1 volume of concentrated sulphuric 
acid, kept cool by ice cold Water. A: sufficient. 
quantity is prepared to permit the addition of B cc. 
to each tube. This reagent is stable for one hour 
only. 
To each tube are added 8 ml. of the acetic 
anhydride sulphuric .acid mixture and th.: tubes are 
then replaced in the 25 °O bath and kept in the 
dark for 25 minutes. Even during the subsequent 
reading in the photoelectric colorimeter care should 
be taken to keep away from light as much as possible 
The solution is read against water in photo- 
electric colorimeter and the result read from a 
calibration curve corrected for reagent blank. 
N0id..AL CO.;TROIS 
As norunl controls, blood was obtained from 
50 healthy subjects (blood donors) within the age 
.range of 20 to 60, and including both men and 
women, between whom there seems to be no 
significant difference in plasma cholesterol level 
(Kountz, Sonnenberg, Hofstatter and Wolff, 1945) . 
The blood was vithdrarn during the afternoon, 2 - 3 
hours after a light lunch. 
The can values, ranges and standard/ 
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THE PLAS.::_ 4 mom STEROL ITú HO RI:La S TEC TS 
Total Cholesterol Free Cholesterol x 100 
rag.per 100 ml rag. per 100 ml T p
Plasma a 
Mean 195 52 26.5 
S.D. 25.6 7.6 1.24 
Max. found . 242 69 29 
T.:in. found. 129 36 24 
Range for 90 , of 161 - 235 42 - 61 
observations. 
-21- 
deviat i o. :s are ^i ven in Table I. The standard 
deviations are not strictly accurate since the 
distribution curve is sli7htly sl-ew. The 
plotted. res.:lts for blond values for cholesterol 
have us pally ; iven a ''s' e:Tr " type of distribution 
curve (Wootton : aelean Smith an,. '"ine M50) ) 
however, and they have bean listed t'h,refore in 
terms of range. FO, of -Lle nor al values riven 
fall betueen the up per and lower 10;: limits, and 
98iß, between the upper and lo:er 1; lir,_its. Thus 
1`70 of normal subjects have blood cholesterol values 
lower than 115 mg., 9 between 115 mg. and 140 mg., 
80 between 140 r r!. and 215 rig., and 1., above 
265 mg. per 100 ml. In clinical practice any 
single result fellin~ outside the 10;- limits is 
considered suspicious; a result which is outside 
the l; limit is certainly abnormal. 
The mean figure for total cholesterol agrees 
well with those in the literature derived from 
a study of 50 or more subjects. -:ith this 
restriction Sunderman and Boerner (1949) list 
r :leans from 194 to 235 mg. cholesterol per 100 ml. 
plasma, it_Z a composite .lean of about 200. The 
range in our series was smaller than some 
previously reported (e.g. Peters and ,=an (1943) 
record a mean of 194 with S.D. = 35.6 but a 
maximum individual observation of 320) , although 
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The free cholesterol concentration in the 
series reported here agrees viell, both as regards 
absolute value and ratio to total cholesterol with 
that reported by Sperry (1936) and by Peters and 
Man (1943) . As in their series the range of 
variation was very small - much less than lias been 
reported by certain other earlier workers. 
RESULTS IN RECENT CORONARY INFARCTION 
The subjects .were 52 patients (50 M and 2 F) 
aged between 42 and 72 who had been admitted to 
hospital because of infarction. The blood for 
examination was withdra ".n, in every case, within 
24 hours of the attack, and usually before the 
administration of any anticoagulant drug. The 
diagnosis was in all cases confirmed by clinical and 
electro card io raphic examination. 
The data are summarised in Table II. The 
means and standard deviations are such as to 
suggest no clearly significant differences from the 
normal controls. Nevertheless, there is a 
tendency for the coronary patients to have slightly 
higher plasma cholesterol levels (both total and 
free) than the normal subjects. This tendency is 
shown for total cholesterol in the distribution 
diagram (Fig 1A) in which there is evident a 
distinct bunching of the coronary patients in the 
upper levels, and in which it is obvious that the 













0 0 0 0j0) 
N d 10 ao O N d to co O N 
N N N N N IIl AI 
1 1 1 1 I 1 1 I 1 1 
O N Y tD ID O N Y ID m O N N N N N 
MG. TOTAL CHOLESTEROL 
PER 100 ML. PLASMA 
B 
N f N Zr) R m Gl O 
MG. FREE CHOLESTEROL F x 100 
PER 100 ML. PLASMA T 
[Tl [F] 
C 
The total plasma cholesterol (A. , the free cholesterol (B), and the ratio (C) in cases 
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way, it can be seen that only 22 of the normal 
subjects, 40 of the coronary infarction patients, 
had a total plasma cholesterol concentration over 
220 rag. per 100 ml. It is still clearer in the 
case of the free cholesterol (Fig.1B) . 
The mean proportion of th e total cholesterol 
existing in the free state is nearly the same for 
the two groups of subjects, but among the coronary 
infarction patients the range is rather greater 
(Fig.1C). Although 38 of the 52 patients had 
F x 100 above the normal mean, the rather high 
T_ 
average in tais group is partly due to the 
inclusion in, this group of six patients with 
F x 100 above 34. In three of these functional 
T 
liver damage was demonstrated by clinical 
examination and by the cephalin- cholesterol 
flocculation test; the others shoed no 
clinical signs of hepatic disease but unfortunately 
tests of function were not done. One of these 
had suffered several previous thrombosis and had 
a total plasma cholesterol of 305 rag. per 100 ml. 
with a free cholesterol of 117 mg. per 100 ml. - 
the highest figure in the series; another Was a 
chronic bronchitic of seven years standiTig; the 
third had, at the time of the coronary thrombosis, 
arterial occlusion at other sites. 
It has already been mentioned that several 
American workers have noted a greater tendency 
to hypercholesterolaemia among the younger than 
amont the older patients with coronary disease./ 
TABLE III 
TIE PLASLA CHOLESTEROL IN RECENT CORUNARY ThFARCT10 - EFFECT OF AGE. 
Total Cholesterol Free Cholesterol F x 100 
mg.per 100 ml rag.Rer 100 ml 
Plasma Plasma 
Over 60 Under 60 Over 60 Under 60 Over 60 Under 60 
Mean 199 229 57 68 28 29 
Range 150 -250 189 -305 42 -73 52 -92 
Number in 
Group 27 25 27 25 
Number above 
Normal Mean. 13 21 20 18 
The results reported. here support this (Table III) 
so far as total cholesterol is concerned. The 
patients over 60 years of age show no significant 
tendency to increased total cholesterol, but 20 
out of 21' had a free cholesterol concentration in 
the plan_ a above the normal mean. The patients 
under 60 years of age, however, had a ._ean total 
plasma cholesterol of 229 mg /100 x:11. (normal mean 
195) and 21 of them, out of 25, were above the 
nor 
. ;al mean. The free cholesterol in this group 
was rather similar to that in the older group, 
altoug;h th.J mean value was high - possibly because 
it included the patients with demonstrable liver 
deficiency; 18 of the 25 were above the normal 
mean. The age difference, therefore, was not 
clearly demonstrated in the case of the free 
cholesterol. 
RESULTS IN ANGINA PECTORIS 
lITHOUT RECENT INFARCTION. 
The results from 20 patients v ith angina 
pectoris but Without evidence of recent coronary 
infarction are summarised in Table IV. 
The patients were drawn mainly from those 
attendin the uut- Patient Department. Some were 
known to have had acute coronary infarction some 
months previously but others provided no evidence 
of infarction. All had suffered recurrent attacks 
of pain over a period of several months and in/ 
TABLa IV 
TO PLASMA CHOLESTEROL Mr ANGINA PECTORIS '','i l'l'HOUT RECi,IdT INFARC.TION. 
Total Cholesterol Free Cholesterol F x 100 
mp.per 100 ml. m.g.per 100 ml T 
Plasma Plasma 
Age Over 60 Under 60 Over 60 Under 60 Over 60 Under 60 
Mean 240 226 65.5 64 27 27 
Range 204- 185- 57- 46- 
314 270 80 86 
Number in Group 12 8 12 6 
Number above 12 7 12 6 
Normal mean. 
Mean 234.7 61.4 26 
Range 
(for 90% of cases) 200 - 271 54 - 80 
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some instances, of more than a year (four years 
in one instance). Those patients who had no 
history of acute infarction were sub. fitted to an 
exercise tolerance test with electrocardiographic 
confirmation of the diagnosis. 
It is evident that these Patients shored a 
much greater tendency to hypercholesterolaemia than 
did those with acute coronary infarction. The 
mean value for the total plasma cholesterol was 
234.7 mg. per 100 ml (normal 195) and, although 
many of the values were within the normal range, 
ii ig.2 shows a clear s': ift of the distribution 
curve. Of the 20 pati :nts in the group, 19 had 
plasma cholesterol in concentration greater than 
th e normal mean. 
:oreover, , analysis of the fifty two cases of 
acute coronary infarction supports the conclusion 
that the occurrence of original pain is a more 
important .factor in relation to hypercholesterolaerni 
than the actual coronary infarction. Of these 
cases, twelve gave a history of Previous attacks 
of pain; the total plasma cholesterol ranged 
from 250 to 305 mg. per 100 ml., with a mean of 
269.5. 
The free cholesterol concentration in the 
plasma showed a similar general, and indeed 
proportional, increase above the noral; the ratio 
of free cholesterol to total cholesterol was/ 
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conse uently unchanged from that sho, n in the 
normal controls... 
Table IV shows also that the age effect 
found in acute coronary infarction does not exist 
in the group of patients Faith .angina pectoris but 
without recent infarction. There is, however, a 
suggestion that the tendency to hypercholesterolaem'_ 
in this group of patients is roughly related to 
the time ich had elapsed since the first attack 
of anginal pain. 
Since :-!any of the patients in this group were 
old and all ':sere over 50 years of age, the question 
of hypertension obviously arose. Among the 
patients with acute coronary infarction those 
giving a history of previous pain (i.e. those with 
the .reatest tendency to hyperci.olesterolaemia) 
had relatively hi gh blood pressure, and anion the 
patients :;ith angina but no acute infarction there 
was some suggestion of a rough correlation betueen 
blood pressure and the plasma total cholesterol 
concentration. There was, however, no clear -cut 
relationship, but it was obviously desirable to 
measure the plasma. cholesterol. in a group of 
hypertensive patients , ithout evidence of coronary 
disease. 
RESULTS IN HYPERTENSION '.:IPHOUT EVIDENCE OF 
CORONARY DISEASE. 
The plas; îa cholesterol concentration ras/ 
a 
-3P- 
TABLE V( a ) 
HYPE RT'E SION 
Total Cholesterol Free Cholesterol x 10C 
mg. per 100 ml mg. per 100 ral T 
Plasma Plas _ -ia 
an 213 67 31 
D. 50.5 17.5 
.x. found. 323 122 50 
n.fou nd. 109 42 25 
.nge for 90: o f 
,bservations . 110 -309 53 -110 26 -44 
unber above 27 41 40 
rmal mean. 
TABLE V(b) 
THE PLASiT_A CHOLESTEROL Iìd HYPERT1Y SION 
Total Cholesterol Free Cholesterol ;, x 100 
mg. Der 10 . ml Mr;. per 100 _ml 
Plasma Plasma 
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examined in 44 hypertensive subjects, (24 raen 
and 20 women) of all ages. Every subject had 
systolic blood pressure above 180 mm Hg or a 
diastolic pressure above 90 ram Hg (or both). The 
general results are sumr_ari sed in Table V. 
The fi 'Aires for total cholesterol are very 
similar to those found in the patients \:7ith recent 
coronary infarction, though the range was rather 
greater and there the same tendency for the 
hi gh c_;r figures to occur among the younger patients. 
There was no sex difference. The free cholesterol 
was distinctly higher, on the whole, than among 
the normal controls or even the patients with 
coronary disease, but the age difference appeared 
to have Vanished. The tendency to increased free 
cholesterol concentrations was so marked that the 
ratio Free:total was considerably above the values 
found in the groups previously examined. This 
change in the ratio was actually more marked in the 
older patients (over 60) in contradistinction to the 
total hypercholesterolaemia which was more marked in 
the younger (below 60) patients. It is tentatively 
suggested that this alteration in the Free:total 
ratio may be ascribed to the effect of arterio- 
sclerolic changes on the functional efficiency of 
the liver. No such decreased efficiency could be 
demonstrated by the cephalin- cholesterol flocculation 
test, except in two cases, with _ x 100 of 35/ 
m 
-36- 
and 50 re spec tiv,:ly, this does not, of course, 
suffice to negative the suggestion. It is :,cam th 
mentioning in this connection that McMichael (1950) 
has, in one post mortem case, demonstrated 
pathological changes in the liver of a severely 
hypertensive patient who showed old healed 
pyelonephritis and _belief has been expressed that 
such changes are commonly associated ith 
hyperten sion. 
The discrepancy between the tot al chole sterol - 
age re lation ship and the ratio -age relationship 
suggest -:d that duration of hypertension rather than 
age might be the determining factor, and the figures 
were re- examined accordingly. When the patients 
were classified in this way, ta'ing 5 years duration 
of hype rte ns ion as the standard, the results were 
as süo.;n in Table VI. It ap -ars that the 
tendency to a total hypercholesterolaemia is rather 
greater among the patients in whom the hypertension 
is of relatively short duration, but it must be 
emphasised that this tendency has not been shown to t 
statistically sig nif is ant. -iith the same caveat, 
though with rather more assurance , it can be 
suggested that the concentration of free chole sterol, 
and, even more mar'cedly, the free total ratio is 
more a7no.:-mal in the long duration group of patients. 
The pro r:ressive change of the ratio with 
increasing dtirati on of hypertension is shown even 




Total Cholesterol Free Cholesterol F x 100 
m;. pe r 100 ml mg. Per loo ml T 
Plasma Plasma 
Over Under Over Under Over Under 
5 years 5 vears 5 years 5 years 5 years 5 years 







204 228 78 65 38 28 
110- _ 109- 53- 38- 32- 25- 
300 323 122 88 50 35 
20 24 20 24 20 24 
7 20 20 21 20 20 
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TABLE VII 
Duration of Hypertension No. of F x 100 
T 
_,ange 
in years Cases 
Mean 
0 - ", 13 28 25 - 31 
2 - 4 11 30.5 26 - 37 
5 - 10 10 36.8 32 - 40 
10 - 15 10 41.0 37 - 50 
Age in years 
40 8 27.5 26 - 29 
41 - 50 12 32 26 - 37 
51 - 60 18 35.5 25 - 43 
61 - 70 5 38 30 - 50 
70 1 31 31 
of the free:total ratio is progressive, only is 
very much greater among tbe patients 
hypertension of over 5 years duration, and it 
should be noted that this coincides .ith 
electrocardiographic evidence of progressive left 
ventricular hypertrophy. Naturally, the longer 
duration p ti -tats tend to be found a7ong the older 
ones but a similar classification on the basis of 
age by decades (Table VIIb) showed a much less 
clear progression in the free :t::tal cholesterol 
ratio, the ranges overlapping much. more completely 
although the means increased. It is justifiable 
to conclude that, although age and duration of 
hypertension are n t completely independent, the 
latter is the more important and possibly the 
fundamental factor. 
Since some degree of renal inefficiency is 
almost inseparable from hypertension of long duratio 
it was necessary to find ,.,hether the a.no=alities 
in the plasma cholesterol were asso.. fated with this 
rather than :ith th :.,ere elevation of the blood 
pressure. In most of the cases, renal function 
was tested by the urea range test. Only two gave 
a comple t -ly normal range (i.e. 3.5,- urea to below 
O. urea) and it was therefore necessary to choose 
arbitrarily some lower standard 7 ich could be 
taken as represe ntinr a 'considerable" degree of 
functional im airmentT; this standard was fixed / 
for 90, , 
observations. 
TABl VIII (a) 
HYPE RTMq SI ON ITH IMP AI TED ''IDITEY ITTTNC TI ON TESTS 
Total Cholesterol ?ree Cholesterol F x 100 
ri . per 0 rig.- r .der -100 r i T 















HYPERTElJSIOiVT 'aIT T'jED KIi.NEY =IC TION STS 
Total Cholesterol Free Cholesterol F x 100 
mr_;. per_ 100 ml mg. doer 100 ml T 
Plas: a Plasma 
Over Under Over Under Over Under 
5 years 5 years 5 years -5 years 5 years 5 years 
duration duration duration duration duration duration 
Me an 207 192 79.8 68 38 28 
Range 136 - 209- 53- 57- 34- 26- 
300 257 122 80 44 31 
Number 
in 
12 6 12 6 12 6 
Group . 
at 2.5,' urea, those failing, to concentrate to this 
level being regarded as showing impairment of 
renal function. Eighteen patients fell .in this 
group, and the figures for plas:.:a cholesterol 
(Fig.VIII) are practically indistinguishable for 
those of the .hole hypertensive group shown in 
Fig.Vl1. Evidently, impairment of renal 
functional efficiency is not, in these patients a 
factor in the abnormality of cholesterol 
metabolism -ehich leads to a very slight tendency 
to hypercholesterolaemia combined with a much more 
definite increase in tie proportion of the total 
cholesterol which remains in the free state. 
RESULTS IN C ONGE STIVE 1-2 ,, ART 
The consideration that the tendency to increase 
in F x 100 in the cases discussed in the preceding 
T 
sections of this pad er might be explained by so7,1e 
degree of liver functional efficiency due to 
interference :ith the circizlation with consequent 
diminution of the supply of etabolites (including 
oxygen) t7 es the cells led to __ e,r,;- 'nati on of 
patients with congestive heart failure. In the se 
there is a similar disturbance ;hick could well 
lead to a similar apparent diminution in liver 
functional efficiency and indeed the condition of 
"cardiac cirrhosis has been desc_ ibed as e. late 
phenomenon in recu lent c once stive heart failure. 
m.,_ / 
Case Number Etiology Liver 
CONGESTIVE IEART FAILU.C. 
Phase 
F x 100 
T 
Complete Recovery Phase 
x 100 
T 
Cephalin- Ascitis Spleen Acute .o of Enlargement 
Total Cholesterol Free Cholesterol Total Cholesterol Free Cholesterol 
Cholesterol Attacks 






























































































































188 50 26 
209 57 27 
216 59 27 
200 57 28 
No t examined but very early failure case. 
Not examined 
Not examined 
1.70 61 30 
155 55$ 
150 56 37 
184 70 38 
185 65 35 













The relevant data from thirteen cases are 
summarised i_n Table 1 . There is an obvious 
diminution in the total plasma cholesterol during 
the acute phase of congestive failure and, since 
the free plasa cholesterol is not similarly 
reduced, the abnormality consists in -a reduction of 
the combined cholesterol. This, of course, cives 
an apparent increase in F x 100, such as is 
T 
commonly found associated with liver disease. The 
clinical examination of the atients during this 
phase s' o-. ed a rough correlation bet-.een the degree 
of liv .r enlarger! nt and the abnormality of F x 100, 
T 
but none between this. abnor mality and the number 
of previous attacks. 
After clinical recove .,y the same patients were 
re- examined. Those who had had not more than two 
previous attacks of congestive heart failure 
showed. an increase in the total plas_aa cholesterol 
to the nor al level ;it h a return of F x 100 to 
T 
normal. In these patients the liver had returned 
to normal size and the cephalin -cholesterol test 
gave a negative result. The patients with 
several previous episodes shoved a much smaller 
increase in the total plasma cholesterol, a 
continuing abnormal value for F x 100, residual 
T 
liver enlargement .and, in r ost cases, flocculation 
in the cephalin- cholesterol test. 
These results strongly suggest that the/ 
-45- 
circulatory failure in the se patients produces 
impa ii gent of the ':epati c func ti oval efficiency and 
that long continuation or repetition of the 
condition leads ultimately to cellular damage. 
It cannot be concluded definitely that the similar 
derangement of the plasma cholesterol associated 
with hypertension and with coronary disease is 
also due to liver. inefficiency. Since, however, 
these other conditions involve vascular changes 
which trust be expected to affect the liver in the 
sale way as does congestive heart failure, the 
conclusion is at least probable. 
-46- 
T11 _ EL-+'IECT OF ?EP ARIN ON TIE' PLAS :iA CHOLESTEROL 
The existence of some connection between 
heparin and blood lipoids was suggested by the 
work of Chargaff et al (1941) and of Hahn (1943) . 
The former r.orleers demonstrated that heparin could 
rupture the bond uniting; globulin -:ith lipoid 
Material in "lipoproteins ", itself combining with 
the globulin. The latter observed that 
intravenous injection of heparin was followed, in 
dogs, by a rapid disappearance of alimentary 
lipaemia. 
The importance of the plasma cholesterol concen- 
tration in relation to the concentration of other 
lipins at once suggested that heparin might have 
sovie influence on this, and in the course of the 
more general investigation of cholesterol 
metabolism described in the preceding pages, the 
opportunity arose of testing this point. This 
subsidiary investigation may conveniently be 
ecorded here.. 
hethod and results 
Subjects: The subjects were nineteen patients 
suffering from 1canthomatosis, nenhrotic syndrome 
coronaa7 infarction or pulmonary infarction. 
Procedure: After a sample of venous blood 





























mg. %. mg. %. mg. %. mg %. mg %. mg %. mg %. 
F. F. F. F. F. F. F. 






T. F. T. F. T. F. 
x Xanthomatosis 520 225 24 324 94 28 300 84 z8 23o 7o 30 245 70 28 444 130 29 450 230 28 
2 Nephrotic 
syndrome 
524 130 25 300 8o 26 305 8o 26 300 84 24 375 xoo 26 425 220 27 ... 
3 Nephrotic 
syndrome 
532 250 28 300 84 24 285 75 26 290 74 25 285 74 25 400 200 25 ... ... ... 
4 Nephrotic 
syndrome 
323 88 27 200 6o 30 205 58 28 215 62 28 220 62 28 300 8o 26 ... ... ... 
5 Nephrotic 
syndrome 
425 120 z8 250 72 z8 245 70 28 265 75 z8 275 75 27 400 220 30 ... ... ... 
Received tromexan hroughou in addition to heparin (on the first and second days only). 
TAME 




24 hours after 
Heparin. 
Cholesterol 
48 hours after 
Heparin 
Cholesterol 
6 weeks after 
Heparin 
Total. Free. %. Total. Free. %. Total. Free. %. Total. Free. %. 
6 Coronary 
infarction 
8,000 units slatirn 
6,000 units 6 hourly 
245 70 28 200 55 27 220 62 a8 250 67 26 
7 Coronary 
infarction 
8,000 units statim 
6,000 units 6 hourly 
230 68 29 200 53 26 210 55 26 238 68 28 
8 Coronary 
infarction 
2o,0oo units statim 
6,000 units 6 hourly 
220 6o 27 189 6o 32 200 56 28 216 62 28 
9 Coronary 
infarction 
8,000 units statim 
6,000 units 6 hourly 
230 68 29 202 6o 29 200 55 27 235 66 28 
Io Coronary 
infarction 
xo,000 units statim 
1o,0oo units 4 hourly 
250 67 z6 290 56 29 210 55 26 257 67 26 
II Coronary 
infarction 
io,000 units statim 
20,000 units 4 hourly 
200 55 27 170 48 29 175 48 27 209 57 27 
12 Coronary 
infarction 
xo,000 units statim 
xo,000 units 4 hourly 
211 53 25 290 54 28 292 54 28 216 59 27 
23 Coronary 
infarction 
1o,o0o units statim 
xo,000 units 4 hourly 
200 75 37 276 66 37 ... ... ... 220 76 35 
24 Coronary 
infarction 
xo,000 units slafim 
,o,000 units 6 hourly 
268 70 26 25o 70 28 255 7o 27 275 8o 29 
x5 Coronary 
infarction 
8,000 units statim 
6,000 units 6 hourly 
235 85 36 205 70 34 210 70 33 230 8o 35 
x6 Coronary 
infarction 
8,000 units statim 
6,000 units 6 hourly 
230 70 29 202 6o 29 ... ... ... 235 68 29 
27 Coronary 
infarction 
xo,000 units statim 
xo,000 units 6 hourly 







24 hours after Heparin. 
Cholesterol 
48 hours after 
Heparin. 
Before Discharge 
6 weeks after 
Heparin. 
Total. Free. %. Dose. Total. Free. %. Total. Free. %. Total. Free. %. 
x8 Pulmonary 
infarction 
255 70 27 xo,000 units statim 
xo,000 units 6 hourly 
210 55 26 225 60 27 257 67 26 
x9 Pulmonary 
infarction 
250 67 26 xo,000 units statim 
xo,000 units 6 hourly 







24 hours after Tromexan. 
Cholesterol 
48 hours after 
Tromexan. 
Cholesterol 
72 hours after 
Tromexan. 
Cholesterol 
96 hours after 
Tromexan. 
T. F. %. Dose. T. F. %. T. F. %. T. F. %. T. F. %. 
29 x Coronary 
infarction 
180 54 3o Tromexan I2 gm. 
Next day o9 gm. 
187 57 30 rqo 58 3o 185 57 30 287 55 
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in therapeutic doses, and further samples of bloo(1 
were withdrawn at the same time each day for five days. 
Free and total cholesterol ,-sere determined in the 
plasma separated from each sample. In 14 cases a 
further sample of plasma was analysed after an 
interval of six weeks, and in the remaining five 
the daily analysis was continued to t! e fifth or 
si °:th day. 
Results: The results are summarised in Table 
X_ which shows that it every instance the adminis- 
tration of heparin was followed by a prompt fall 
in the total concentration of cholesterol in the 
plasma and a proportionate fall in the concentrates 
of free cholesterol. These falls were greater 
in those patients -with marked hypercholesterolaemia. 
Five patients, one with xanthomatosis, the 
others cases of nephrotic syndrome, had initial 
plasma total cholesterol concentrations ranting 
from 323 to 532 mg. per 100 ml. Plasma (the normal 
range determined in this laboratory is 195 ± 25) , 
and these fell by 120 to 232 mg. in 24 hrs. du: ;ing 
which patients had each received 30,000 units of 
heparin given in divided doses (12,000 units, 
'initially followed by 6,000 units at six hour 
intervals) . The free cholesterol concentrations, 
initially absolutely high but forming the normal 
proportion of_ the total, fell similarly so that 
the ratio free; total cholesterol was unaltered. 
During the second 24 hour period, in ' sp ite of/ 
-5 0- 
further administration of 10,000 units of heparin 
(one dose) there was no further decrease in the 
plasma c ncentration of free or total cholesterol. 
During the third 24 hour period, with no further 
administration of heparin the total cholesterol 
concentration remained unaltered but thereafter 
there was a rapid rise towards the initial level, 
which in two cases had been practically reattained on 
the fifth day. The concentrations of free 
cholesterol behaved similarly except that the 
restoration of the initial concentration was more 
nearly complete on the 5th day. 
The fourteen patients v;ith coronary or 
pulmonary infarction had received no heparin prior 
to the observations reported in Table Xj and Xe 
and had just been admitted to hospital with a 
fresh coronary thrombosis or pulmonary embolism. 
The initial total cholesterol concentration ranged 
from 200 to 268 mg. per 100 ml - i.e. in or 
slightly ab ve the upper half of the normal range, 
and free c holesterol formed the normal percenta e 
of the total. Each of these patients received 
heparin in r,ivided doses for 24 to 48 hours. 
Twenty four hours after ' the last dose of heparin, 
the total c holesterol had fallen by amounts, 
ranging from 21 to 60 mg. per 100 nil. plasa, Mich 
were not proportionate either to the heparin dosage 
or to the initial level. The free cholesterol. 
values fell proportionately. For therapeutic 
purposes, administration of heparin was followed 
by-treatment with tromexon, but this had, of course, 
no effect on the figures just quoted. Forty 
eight hours after cessation of the heparin 
treatment, and 24 hours after the first dose of 
tromexon the concentration of cholesterol in the 
plasma were substantially unaltered. Daily 
determinations of the plasma cholesterol then 
ceased but six eeke later t'_ concentration had, 
in all cases, returned to the initial level. 
These results shoed the profound influence 
of heparin on the plasma cholesterol concentration 
but did not indicate whether tromexon had a 
similar effect. The apparent absence of effect 
of tromexon in the cases quoted in Tables _Xb and 
..Xe is not conclusive , because as is sho :n in 
Table _ a. the fall in plasma cholesterol produced 
during 24 hours administration of he :.:grin as not 
increased when the drug: was !Jven for a second 
period of 24 hrs. 
Other cases, hov.ever, show _uite clearly 
that tromexon does not lower the plasma cholesterol 
level. Thus , in case I (Table _x=a) the plasma 
cholesterol concentration rose towards the 
normal level at the sa:.:e time as in the other cases 
of this group although it alone was receiving 
tromexon. Further, during continued administration 
-52- 
of tromexon for six more days, the plasma 
cholesterol was maintained at 450 mg. per 100 ml. 
Yore clear cut, hor,ever, is the evidence from a 
patient, suffering from coronary, thrombosis, who 
received tromexon therapeutically for about three 
wee ".,s, but was at no time given heparin; the plasma 
cholesterol did not fall below the initial level 
of 190 mg. per 100 nil. on the second day of 
tro -exon nor on any of three other occasions. (Table _d) 
Conclusions: It is evident that heparin is 
capable of lowering markedly the concentration of 
cholesterol in the plasma, that this effect is 
produced eually in free and esterified cholesteról, 
that it is greater when hyperci_olesterolaemia exists 
than when the cholesterol level is normal, and that 
when the lowering has been produced continued 
administration of heparin has no further effect. 
The other anticoagulant tested, tromexon, had no 
such action. 
Tie twelve patients in these series who were 
suffering from coronary thrombosis had plasma 
cholesterol concentrations which were not 
significantly above the normal range, although all 
were above the nor al average. The free cholesterol 
formed the nor--.al proportion of the total. 6imilar 
figures have been obtained by t' author in some 
50 other cases reports 7, eArlir;r in this. thvsis. / 
-53- 
This observation, in agreement i th that of Hall, 
Morrison and Cheyney (194:1, does not support the 
idea that hypercholesterolaernia is the cause of 
coronary o theroma . Nevertheless, the metabol i sn 
c° cholesterol may well undergo profound alteration 
without marked change in the plasma concentration 
and the bulk of evidence relating the occurrence 
of atherol _a Tith abnormal cholesterol -tetabolism 
is too 7r-at to be ignored. It is tenting, 
though hi7hly s neculative, to relate the stability 
of cholesterol in the plasma, the concentration of 
heparin or similar amino -sugar esters, and the 
mast cells which many workers believe to be 
concerned in the production of such substances. 
=uch indirect evidence indeed, can be adduced to 
lend plausibility to such a speculation, but 
until direct evidence is found, it is :riser to 
be content with dra ind; attention to the possible 




This suggestion that vascular degenerative changes 
slowly produce some abnormality of cholesterol 
metabolism is strengthened by the finding that in 
angina pectoris the tendency to hypercholesterolaernia 
is roughly proportional to the period over which 
anginal pains have been observed, and that, in the 
same subjects there is a rou;z.,h parallelism between the 
plasma cholesterol and the blood pressure. It seera.s 
that the level of the plasma cholesterol and the 
degree of hypertension alike may be,overned by the 
extent of the degenerative lesions in the blood 
vessels, which is a function of duration. 0n this 
basis, an acute coronary infarction may occur without 
widespread degenerative a. °terial changes, and 
consequently with little elevation of the plasma 
cholesterol. This is not to deny the proposition 
that the atheroraatous lesion involves the deposition 
of cholesterol or cholesterol esters derived from the 
plasma; it is in agreement with the idea that there 
is some inherent or at least primary fault in the sub - 
intimal tissues; but it suggests that given this 
primary fault, the development of the lesion -may begin 
without pre- existing hypercholesterolaem i a to which, 
however, it may lead in the course of tine. This/ 
)5- 
hypothesis of the sequence of events is equally 
consistent with the frequent occurrence of atheromatous 
changes in diabetes with hyperbholesterolaernia and in 
nephroscierosis without constant hypercholesterolaefia. 
The suggestion that hypercholesterolaemia is the 
sequel to, rather than the cause Of, atheromatous 
changes does not oppose, but is indeed supported by 
the distribution of these chances in the vascular 
system, a distribution which led Anrep, Davis, Voihard 
(1931), Gregg ( 1934) , Johnson and Dipalma 4939), 
Mo schkow i tz (1942) and others to develop the theory 
that atheromatous change is the result of excessive 
localised intravascular pressure. It was observed 
by Davis and Gregg (1934) and 
Johnson Dipalma (1939) that the left coronary artery 
suffers a high hydrostatic pressure; Gregg (1940) 
noted that because of the smaller intramural pressure 
in the right ventricle than the left, the right 
coronary artery suffers a smaller hydro -static pressure 
than the left. 1.1oschkowitz (1942) has confirmed 
pathologically that those arteries which support a 
high intravascular pressure are the most susceptible 
to atheromatous chan;e.. 
The actual production of thrombi may be 
attributed to some abnormality of the clot tiny 
mechanism which is potentiated by the local injury to 
the artery wall (although it is not clear whether such, 
-;.6- 
clotting abnormality must necessarily be postulated.). 
It is fairly well established (Wright 1949), Downe 
(1940), Jorpes (1939) that the ?east cells of the 
liver and the smaller blood vessels produce heparin. 
Others ( Jorpes, Eioliugren and Wilander (1937) , 
Levene, Lopersuarez (1, 18) have extracted a heparin 
like substance from the -wall of the aorta and 
Fab r (1949) has demonstrated that deposits of 
cholesterol are found only where ethanol resistant. 
metachromasia are present. He (1946) has further 
observed that the depletion of cholesterol is greater 
in these sites in hypertensive patients, though 
without Lared increase in plasma cholesterol. 
Although the observations are not yet sufficiently 
complete for detailed publication, the writer has 
found mast cells in the walls of the aorta and coronary 
artery of normal human subjects, but in those of 
subjects who had suffered from atheromatous changes 
and it seems appropriate to interpolate here a very 
brief account of these observations. 
As mast cells degenerate very quickly it is very 
difficult to obtain human tissues in a state suitable 
for their detection. The three cases of coronary 
disease studied for mast cells were obtained from 
patients who died accidentally and on whom post morte!-/ 
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FIGURE 4 
Normal Hunan Aorta stained !i th Tolui dine 
Blue - showing normal rast cells. 
5 
Normal human Aorta stained ritte Sudan Black - 
showing :east cells. 
FIGURE 6 
normal human Coronary Artery stained with Sudan 













Atheromatous human Coronary Artery stained .ftth 
Toluidine Blue - shoviing less number of mast cells 






â. e 4P '4%1 
_ski III 
Atheromatous human Aorta stained viith Toluidine 
Blue - showin,c7, less number of mast cells and rupture 
of mast cells, and abundance of granules coming out 
of cells. 
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examination was done Within 5 hours of death. The 
tissu -es ,.:ere fixed in 80 d' alcohol for +reservation of 
mast cells, and frozen sections were later stained 
with Toluidine Blue which is claimed to be specific 
for .last cells (F ig.4) . Other ti ssues were fixed 
in formalin and then frozen sections ::ere dipped in 
warm alcohol or ether- acetone mixture to dissolve the 
lipid. It ';'as observed by o 1i slocki, Bunting, Demsey 
(1947) that Sudanophilic granules of past cells fixed 
in formalin are not dissolved by ether- acetone or 
alcohol. In sections placed in these solvents from 
1 -5 hours and then stained Ili th Sudan black, the fatty 
deposits stained a clear black. 'Figures 5, 6 show 
clearly the presence of mast cells in the walls of the 
aorta and coronary artery of the normal subject but 
not in these sites in the three atheromatous subjects. 
In other two atheromatous subjects the mast cells 
though not completely absent, had undergone great 
degeneration (F igs.7 and S) . 
One section of lung obtained from á case of 
pulmonary hypertension and anoth r section from a case"- 
Buffering from pulmonary tube re ulo sis but pith no 
atheromatous change viere stained pli th ;i- 'oluid ne B= 
The section from the former case showed very few mast 








.,,, l`_ . r- 
a 
. . ir` arn. 
4.,,t_ s 
N 
Section of human Lung from patient of pulmonary 
Hypertension stained with Toluidine Blue - showing 
a few mast cells. 
l'.43 
_i141) ti 
Section of human Lur_g from a case of 1'ul ionary T.B. 
stained with Toluidine Blue - showin,r abundance of 
ma s t cc lls . 
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tuberculosis case in which a large number of mast 
cells was demonstrated (Figs.l2 and 13). It is 
striking that ' hypdc iolesterolaemia has frequently 
been observed in simple tuberculosis and the author 
has also found it in a number of cases. 
This evidence is admittedly scanty but it is 
undoubtedly suggestive of a close connection between 
mast cells, atheromatous change and cholesterol 
abnormalities and if with extended observations the 
local disappearance or degeneration of mast cells is 
found to be associated regularly with atheroma a 
causal relation may eventually be established. 
MYiean {bile it may be tentatively suggested that due 
sometimes to high stress and strain on the arterial 
walls as a result of hypertension and sometimes to 
other factors (e.g. food) there is damage to the mast 
cells with consequent reduction in heparin production 
so that the power to rupture the-globulin-lipid bond 
fails since this appears to be one of the functions of 
h parin (Chargaff, 1942) . A considerable gap is 
produced in the subintima of the vessels by the 
shrinkage of mast cells and because of affinity of 
these cells for lipids cholesterol gains entrance into 
the damaged mast cells. The affinity of mast cells 
for fat has been proved by Stenhaus, Ciaccio, Heinzman, 
Lombardo (1906) and Unger. The last mentioned of/ 
-63- 
these workers, indeed, interprets mast cells as far 
transport cells on t]:ie basis of experiments 
involving; the injection of fat and soaps, l'aber (194 ) 
has also observed deposition of cholesterol in these 
subintimal places where ethanol- resistant 
metachromasia is present. These results and 
interpretations receive support from the observations 
that the mast cells disappear from sites Where 
atheroinatous changes have taken place. 
Alder (1923) observed increase in number of mast 
cells in anae:1.ia and carcinoma. Although the figures 
are not recorded in this thesis, the observation has 
been made, in anaemia and in carcinoma, of low plasma 
cholesterol levels, both total and free with a slight 
change in F x 100, a finding in agreement with that 
T 
of Bloor (1916) , Bloor and Iîacpherson (1917), 
Dubin (1910, Ericson, Williams: Rummell, Lee, "acy 
(1937) , Fein (1919) , Hodes, Sperry, Anderson (1943) , 
1u1 leg (1930) , Muller and Heath (1933) , Oser, Barr 
(1925) . This finding is in agreement also with the 
view that increase in the number of mast cells produces 
extra heparin in the system and thus produces a 
lowered concentration of plasma cholesterol; it is 
a proved fact that in these groups of cases at]?eroma 
are rare. 
It is evident from the data reported in this 
thesis and elsewhere that true hypercholesterolaemia ici 
_64- 
not found in acute coronary infarction, but 
nevertheless there may be a change of the cholesterol - 
globulin fraction. There may be possibilities of 
cholesterol- globulin complex alteration i»ithout much 
irimediate change in the total cholesterol of the 
plasma, and, with tissue injury and the natural 
chemotaxis for cholesterol by subintimal tissue, there 
may be excessive deposition of cholesterol in the 
subintimal tissue as is suggested by Faber (1946,1949). 
It is permissible to speculate whether a deficiency of 
heparin, produced by mast cell distinction, may so 
alter the coagulability of the blood .as to produce a 
tendency to thrombus formation at least on a 
favourable surface. It is permissible further to 
speculate whether a prolonged deficiency of heparin 
may be a factor in the hypercolesterolaerria which is 
associated ith athercriatous changes of long duration; 
this is in agreement with the observation (Basu and 
Stewart, 1950) that injection of heparin produces a 
decrease in the plasma cholesterol concentration. 
But, whatev- -r the m. chanisn, our observations indicate 
that the increase in the plasma cholesterol concentrati 
follows the atheroma toes changes (being, therefore an 
effect and not a cause) and that this increase does not 
involve a defect in the cholesterol esterifying 
rae c han ism. 
In hypertension the position ,may be a :Little 
-65- 
differe;mt.. Again, duration is the important factor. 
The mechanism, associated uith vascular change, may 
slowly tend to an increase in the total plasma 
cholesterol, but this tendency is less :_ar'_ :ed than is 
found in the patients with anginal pains and 
atheroïratous rather than arteriosclerotic changes. 
The hypertensive patiu__ts -:;hose abnor::?ality _.s of long 
duration soir-I rather an increase in time free cholesterol 
with a con segue nt rise in t':e value of F x 100 which 
T 
is of the same order as is found consistently 
associated hepatic functional deficiency. 
Alt hour!» r! few hype rt n sive pat i n is have any such 
deficiency de:- ::,_onstreble by other function tests, it is 
noteworthy that some degree of fatty infilt_ation of 
the liver is a common post-mortem i indin.g-, in such 
patients. ì:oreover,a similar increase in ' x 100 has 
T 
been found in cases of congestive heart failure 
(Hawkins, 1934, Can tar ro,, 1935, Epstein, 1936) in 
which as we have found, .then repeated failures may 
lead to a deficiency demonstrable in other ways - 
cardiac cirrhosis. There is a strong suggestion 
that the abnormality of the plasm cholesterol in 
hypertension, whilst in part due to the causes which 
produce vascular degeneration, are largely the result 
of "hypertensive liver deficiency" - a supply lack in 
the earlier stages which as in congestive heart/ 
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failure may lead ultimately to actual cellular 
damage. 
It is, however, clear that on the evidence 
presented the abnormalities of the plasma cholesterol 
in angina pectoris, in hypertension and in congestive 
heart failure cannot all be ascribed solely to the 
effect of hepatic deficiency. For i; }lereas in the first 
two of these conditions there is a Slight tendency for 
the total cholesterol to be raised and a more marked 
tendency for the free cholesterol to be increased with 
a consequential change in the ratio, congestive heart 
failure is characterised by a decrease in the total 
cholesterol with no change in the free cholesterol. 
It is the disproportionate change in-the free and 
total cholesterol concentrations with an increase in 
F x 100 /T which in all these conditions suggests 
hepatic functional impairment as a common factor. 
This, hog =;ever, seeds to be superimposed on other effect 
hick may be due to diverse causes It is possible 
that in congestive heart' failure the hepatic damage 
may have progressed so far as the result of elarkedly 
defective blood supply that the liver can n longer 
synthesise cholesterol adequately isfhereas minor 
degrees of da"lage (such as can, at most, exist in the 
other cases studied) affect rather the esterifying 
and possibly the excretory powers. On the evidence 
available, however, it is more reasonable to suppose/ 
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that the atheromatous changes in the blood vessels 
themselves produce conditions which tend to disturb 
the normal plasma cholesterol distribution and that 
the circulatory deficiency causes impairment of the 
hepatic functions which lead to further abnormalities 
in the plasma cholesterol. 
-6f3- 
SUi:i. .RY 
1. The plasma cholesterol from 50 healthy subjects 
(blood donors) within the age range 20 to 60, 
was 195 rngb + 25.64 and Free Cholesterol 52 mg 
7.59, F x 100 - 26.5 + 1.24. 
T 
2. Acute Coronary Infarction. 
(a) The plasma cholesterol level has been studied 
in 52 acute coronary infarction cases. The total 
cholesterol mean was 212 mg per 100 nil. + 39.2; 
the free cholesterol was 62 r,1gr.1s:- + 13.5; 
F x 100 was 29 + 3.3.. Only 22/J of the normal 
T 
subjects, hut 40¡ of the coronary infarction 
patients had a total plasma cholesterol concentrati 
over 220 rag;, per 100 ml. of plasma. 
(b) The proportion of the total cholesterol 
existing in the free state is, on the average, 
nearly the sa.¡:e for the two groups of subjects 
yet 38 of the 52 coronary infarction patients had 
F x 100 above the normal :1e an of 26.5 (due to 
T 
inclusion in this group of six patients ':;ith F x 
T 
above 34) . 
(c) The patients over GO years of age show no 
significant increase of total cholesterol but 20 
out of 27 had a free cholesterol concentration in 
the plasma above the normal _Ban. The patients 
under 60 years of age had a r.ean total plasma/ 
n 
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cholesterol of 229 mg. per 100 ml. (norma1 mean 
195) and 21 of then out of 25 were above the 
nor -,al mean. The free cholesterol was rather 
similar to that in older group. 
(d) In 12 patients rho had been suffering from 
previous pain, the total plasma cholesterol 
ranged from 250 - 305 mgï,; with a mean. 209.5. 
(e) There is thus some slight tendency in acute 
coronary infarction for the total plasma 
cholesterol to be increased, a tendency which is 
greater in the younger patients. The free 
cholesterol is much more regularly increased but 
the increase is not great and is independent of 
age. 
3. Angina pectoris v?ithout recent infarction. 
(a) 20 patients were studied in this group. The 
total cholesterol mean was 234.7 rmg;;Free 
Cholesterol mean was 61.4; 1? x 100 was 26. 
T 
(b) These patients showed a much greater tendency 
to hypercholesterolaenia; of the 20 patients 
19 showed plasma cholesterol greater than normal 
me an. 
(c) Free cholesterol concentration in the plasna 
showed a similar general and indeed proportional 
increase above the normal ,man, the value of/ 
-70- 
F x 100 remaining unchanged. 
T 
(d) The age effect found in acute coronary 
infarction did not exist in this group of patients 
(e) The ten dency to hype rcholesterolaeniia is 
roughly related to the time ela :sed since the 
first attack of pa in. 
4. Hypertension without evidence of Coronary Disease. 
(a) The plasma cholesterol concentration was 
examined in 44 hypertensive subjects, of all ages. 
The total cholesterol was 213.mg + 50.5; 
Free Cholesterol was 67 + 17.5; F x 100 was 31. 
T 
(b) The figures for total cholesterol are very 
similar to those found in the patients with 
recent coronary infarction but the free 
cholesterol was distinctly higher on the whole, 
and the ratio of Free Total was consequently 
considerably above the normal mean and showed an 
average of F x 100 = 31. 
T 
(c) The abnormality of the Free: Total ratio is 
progressive and_is very much greater among the 
patients with hypertension of over 5 years 
duration. The to tal an ah o vied cholesterol for 
over 5 years duration. The total mean showed 
cholesterol for over 5 years duration of/ 
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hypertension was 204 mg,, Free 78 molls ALL and 
- 
T 
(d) Duration of Hypertension rather than the 
age of the patient appears to be the 
fundamentally important factor. 
5 . Hype rten sion with im.oaired !ddney yunc Lion. 
(a) 18 patients were studied in this group. 
The to tal cho le s to ro 1 nie an was 217 me d'; Fre e 
Cholesterol mean was 71 mg-:is =; F x 100 was 32. 
T 
(b) The figures for plasma cholesterol - are 
practically indistinguishable for those of the 
whole Hypertensive ,°oup, and it appears that 
renal efficiency as such is not a factor in 
de to /mining the abnormality or otherwise of the 
plasma cholesterol level. 
6. Congestive Heart Failure. 
13 cases were studied in this group, during the 
acute illness and ]a ter after recovery. 
(a) The abnormality cons is is in a reduction 
of The combined cholesterol of the plasma. 
(b) There is a rough correlation be tween the 
degree of liver enlargement and abnormality of 
F x 100. 
(e) The patients with several previous episodes/ 
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shoved much smaller increase of total cholesterol 
during the recovery phase and in these F x 100 
T 
showed a continuing abnormal value wi th a 
residual liver enlargement and floc cula tion with 
cep hal in -c ho le sterol. 
'7. Injection of heparin causes a fall in the plasma 
cholesterol proportionately distributed between 
the free and combined fractions. The fall is 
greater -;-:hen the ini ti al piasm.a cholesterol 1 eve 1 
is high. Tromexan does not show this phenomenon 
8. The walls of normal human aorta and coronary 
artery have been shown to contain mast cells. 
With atheromatous changes in these sites the 
mast cells disappear or shots degeneration. 
O. On the basis of these findings it is suggested 
that changes in the plasma cholesterol are the 
result rather than the cause of vascular disease 
whether this effects the coronary artery in 
particular or not. It is further suggested 
that vascular degeneration by interfering with 
the supply of blood ID the liver slowly 
produces functional deficiency of that organ 
and that the changes in the free cholesterol of 
the plasma must be referred at least largely to 
this. In vascular di sease of long duration/ 
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the liver impairment may become irreversible 
and may account secondarily for the changes in 
the total cholesterol *which seem to occur later 
in the history of angina pectoris or hypertension. 
It is further suggested that a factor in the 
plasma cholesterol changes y be de f.en erati. on of 
the mast cells in the arterial walls (observed); 
lung (observed) and liver (not Diet observed but 
inferred as a probable result of interference 
with the blood supply if not a primary phenomenon) 
this sapestion however is :lade tentatively 
because the direct evidence is still slight 
although much indirect evidence can be adduced 
in its support. 
AP PEN I= 
DETAI LED JSTJLTS ST.T IS ED LI 
TABLES 1 - 
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TABLE I 
YL:'S.:A CIIO E STLROL 1RATIOiv I.Oiï:ytiT PERSONS 
Case . Chol. per 100 
F x 100 
T 
Case mg. Chol. 7er 100 
' x 100 
T 
No ml of 21 a sr+l a 
TOTAL 
No I!11. of Plasma 
FREE FREE TOTAL 
1 42 161 26 28 47 166 28 
2 50 190 26 29 57 223 25 
3 46 130 . 25 30 55 190 28 
4 50 185 27 31 54 192 28 
5 50 204 24 ? 42 161 26 
6 50 196 25 33 50 190 26 
7 54 192 `38 34 50 186 26 
8 36 x 129 yi 27 35 54 200 27 
9 44 176 -24 36 61 223 27 
10 50 186 26 37 69 242 28 
11 50 181 27 38 46 166 27 
12 54 200 `? 7 39 50 196 25 
13 57 209 `'7 40 57 209 27 
14 57 214 26 41 55 190 28 
15 61 228 26 42 69 235 29 
16 57 212 27 43 50 185 27 
17 50 176 28 44 38 13'' 28 
18 46 166 27 45 46 178 26 
19 46 166 27 46 57 214 26 
2.0 55 190 28 47 61 228 26 
21 54 205 26 40 57 212 27 
22 54 202 26 49 55 210 26 
23 69 AN 242 HA 28 50 50 181 27 
24 69 236 29 
25 57 223 25 
26 61 223 27 













= 52 ne per 100 ml 
Range for 90L of observations 
Standard Deviation = + 7.59 
Mean = 195 rag per 100 ml 
Range for 90,- of observations 
Standard Deviation = + 25.64 
(Jean = 26.5 






x Lowest value-. found 
x* High. st value found 
ABLE 2 
ACUTE CORONARY IN= TION. 
NO. AGE SEX DIAGNOSIS CHO ;'SThROL 
mp; - per 100 ml of plasma 
E.C.G. 
DIAGi OSIS 






PAIN FREE F ' 
T 
1 60 M C.T. 185 50 27 F Nil Not done + 110 
90 
2 62 M C.T. 166 53 32 + Nil Not done + 120 
80 
3 70 M C.T. 164 42 26 + Nil Not done + 110 
75 
4 64. C.T. 152 53 34 ++ Cholesterol + 100 
Cephalin 80 
+ 
5 67 ?: C.T. 1 0 46 26 4- Nil Not done + 120 
80 
60 M. C.T. 216 59 27 + Nil Not done + 105 
7 60 M C.T. 219 57 26 + Nil Not done + 110 
86 
8 50 M C.T. 269 73 27 Nil Not done + 160 
90 
9 61 M C.T. 271 73 26 Nil Not done + 140 
80 
10 60 I :I C.T. 250 65 26 Nil Not done + 145 
95 
11 69 Iyí C.T. 212 57 27 + Nil Not done + 120 
90 
ACUTE CORONARY INF1iRCTION (CONTD) . 
NO. AGE SEX DIAGN OS IS CHOLESTEROL E .C. G. LIV ER LIVER PAIN 
mg - Per 100 ml of plasma DIAGNC6I S FUNCTION PREVIOUS NO BLOOD PLELAAPIcS 
TOTAL FREE Fib TEST PAIN PAIN PRESSURE 




12 50 M C.T. 204 52 25 + lTi l No t done + 110 
25 
13 62 M O.T. 187 57 30 + Ni Not done + 110 
70 
14 64 M C.T. 190 46 24 + Ni1 Not done + 120 
88 
15 61 Ni C.T. 200 53 26 + Nil Not done + 118 
90 
16 59 M C.T. 166 46 27 + Ni1 Not done + 125 
70 
17 50 M C.T. 220 60 27 + Nil Not done + 110 80 
18 49 M C. T. 235 67 29 + Nil Not done + 120 
96 
19 61 M C.T. 15" 40 26 + Nil Not done + 100 70 
20 67 M O.T. 167 50 29 + Nil Not done + 120 95 
21 54 M C. T. 189 60 31 + Nil Not done + 120 85 
IN AitCTION (CONTD.). ACUTE CORONARY 
NO. AGE SEX DIAGINS IS CHOLESTEROL 
ri, per 100 r11 of plasma 







PAIN BLOOD REMARKS 
PREVIOUS NO PRESSURE 
PAIN PAIN ON DAY OF 
AND NEXT 
DAY 
22 56 M C.T. 220 67 30 + Nil Not done 105 
90 
23 58 M C.T. 916 60 27 + Nil Not done 110 
85 
24 46 M C.T. 202 60 29 + Nil Not done + 110 
?' J 
25 68 . T . 177 54 30 +il Not done 120 105 
90 70 
26 57 II C.T. 205 70 34 .4- += Cholesterol 130 
Cephalin 94 
++ 
27 68 M C. T. 250 80 32 + Nil Not done Yes 140 
90 
28 '68 M C.T. 176 66 37 + Nil Not done + 110 rterial 
80 
29 58 M C.T. 305 117 38 + Nil Not done 150 
95 
30 42 M C.T. 275 92 29 + Nil Not done + 150 
85 
31 63 M C.T. 232 70 30 + Nil Not done + 120 
85 
32 49 M C.T. 190 70 36 + Nil Not done 120 105 Chronic 
60 60 Bronchitis 
ACUTE CORONARY INFARCTION (C0NTD) . 
NO. AGE SEX DIAGNOSIS CII3 , ST COI, E. .G. LIVER LIVER PAIN BLOOD 
mg, per 100 rml of nlasr-a DIAGNOSIS .r'UiICTI ON PREVIOUS NO PRESSURE 
TOTAL FREE F TEST PAIN PAIN ON DAY OF 
T ADi;.MIS SI ON 
AND TEXT 
DAY 
33 63 M C.T. 150 48 32 + Nil Not done + 120 
80 
34 60 M C.T. 235 68 29 + Nil Not done + 110 
90 
35 61 M C.T. 240 68 28 + Nil Not done + 150 125 
95 85 
36 47 M C.T. 260 70 26 + Nil Not done + 140 
95 
37 72 M C.T. 180 64 28 + Nil Not done + 110 
75 
38 52 M C.T. 270 86 29 + Nil Not done + 175 145 
95 80 
39 61 M C.T. 185 57 30 + Nil Not done + 120 
80 
40 58 M C.T. 228 61 26 + ïTil Not done + 130 
90 
41 52 F C.T. 252 70 27 + Nil Not done + 120 
70 
42 62 M C.T. 238 61 26 + Nil Not done + 110 
75 
43 63 :+ ;ï C.T. 204 65 31 + Nil Not done + 110 
70 
REMARK S. 
NO. AGE SEX DIAGNOSIS 
ACUTE CORONARY INFARCTION (CONTD . 
CHOLESTEROL E. C.G. LIVER LIVER PAIN BLOOD REMARKS 
mg`:? per 100 ml of plasma DIAGNOSIS FUNCTION PREVIOUS NO PRESSURE 




44 51 M C.T. 228 65 28 + Nil Not done + 110 
60 
45 58 F C.T. 223 61 27 + Nil Not done + 105 
75 
46 51 M C.T. 250 65 26 + Nil Not done + 200 170 135 
160 130 100 
47 55 M C.T. 129 46 35 + + Cholest3rol + 110 
Cephalin 95 
+ 
48 68 M C.T. 209 57 27 + Nil Not done + 112 
80 
49 53 M C.T. 257 80 31 + Nil Not done Yes 160 145 
ITT 85 
50 59 M C.T. 209 61 28 + Nil Not done No 125 
70 
51 55 M C.T. 266 80 31 + Nil Not done Yes 170 M0 
I-00 80 
52 45 M C.T. 271 73 26 + Nil Not done + 135 
90 
53 62 Tv C.T. 204 65 31 + Nil Not done + 100 
75 
.G. All Electrocardiographic examinations were done by standard and unipolar limb and chest leads. 
C.T. = Coronary Thrombosis. 
TABLE 3 
ANGINA PEOTORIS. 
NO. AGE SEX BLOOD 
PRESSURE 
CHOLESTEROL 
m `,> per 100 ml of plasma 
F 
T 




Exercise TOTAL FREE 
1 54 I T 150 185 46 24 ± 4 months -ve -ve 
96 
2 67 180 204 57 27 + 8 months -ve -ve 
110 
3 79 i, 140 228 61 26 + i year -ve -ve 
100 4 months 
4 64 178 314 80 25 + 4 years -ve +ve 
114 
5 53 M 145 230 65 28 + 2 -1 years -ve +ve 
95 
6 56 F 140 220 64 9 + 1 year -ve -ve 
96 
7 58 F 150 200 54 27 + 3 years - ve -ve 
96 2 months 
8 66 P:í 160 235 69 29 + 6 months + 
110 
9 '70 M 155 223 61 27 + 1 year + 
105 
10 '74 M 18 5 242 69 28 + 9 months + TT 
11 56 M 155 209 57 27 + 6 months -ve +ve 
96 
12 68 160 216 65 30 + 2 years -ve +ve 
96 
ANGINA PECTORIS (CONTD). 
NO. AGE SEX BLOOD 
PRESSURE 
CHOLESTEROL 
mg per 100 ml of plasma 




Exercise TOTAL FREE Fig 
T 
13 70 11 180 271 73 26 + 3 years + + 
If 5 
14 67 F 146 252 69 27 + 1 year -ve +ve 
96 
15 ' 56 M 140 231 60 25 + 9 months -ve -ve 
86 
16 50 200 270 86 29 22 years -ve +ve 
777 
17 61 TL.; 160 238 61 25 + 3 months -ve -ve 
T00 
18 63 I:. 150 228 61 26 + 5 months + + 
110 
19 52 M 170 266 80 30 + .3 years -ve +ve U 
20 65 T,í 150 233 61 26 6 months -ve -ve 
loo 
E.C.G. All Electrocardiographic examinations were done by standard, unipolar limb and chest leads. 
(i) -ve - Nothing to suggest. 
(ii) +ve - Definite finding of Angina. 
(iii) + - Tests not done as these patients suffered from 
acute coronary infarction before. 
HYPE RTE SI. ON 
No. Age Sex Blood Duration CFI OLESTEROL Liver 
Pressure of mg per 100 rzl. of plasma Liver kidney Electro- 
mm Hg Illness Total Free Free- Function Function car dio- 
Totalt' Tests Tests raphic 
Cholesterol Ohange s 




































































































0.4 % -1004 
3;= -1018 
0.5;--1004 





















No. Age. Sex Blood Duration CHOLESTEROL Liver Liver Kidney Electro- 
Fressure of mg '/T per 100 ml. of plasma Function Function cardio- 
mm Hg Illness Total Free Free Tests Tests graphic 




9 50 M 230 1-i 235 69 29 -ve -ve 2.8, -1020 No 
130 years 0.4 -1004 Abnormality 
10 39 M 150 12 228 61 26 -ve -ve 2.5 ¡L -1016 " 
110 years 
11 52 F 210 1? 228 70 30 -ve -ve 3 ¡ -1022 " 
120 years 0.4iÚ -1000 
12 55 F 198 1 223 61 27 -ve -ve 3.2;: -1018 " 
115 years 0.3iß -1004 
13 50 M 210 2 269 73 27 -ve -ve 3.6;- -1020 " 
120 years 0.4 -1O02 
14 44 M 195 2 176 53 30 -ve -ve " 
1i0 years 
15 45 F 190 2 220 60 27 -ve -ve 
ft 
110 year s 
16 79 M 200 3 204 65 31 -ve -ve 
" 
II5 years . 
17 40 M 190 3 272 80 29 -ve -ve 
" 
110 years 
ITYPE RTEN SI ON 







mg;= ne r 100 ml. of plasma 
Total Free Free, 
Tot al 









18 45 idI 200 3 204 65 31 -ve -ve Urea No 
12Ö ye ars Range Abnormal i ty 
19 '45 F 180 32 188 50 26 -ve -ve if 
115 years 
20 59 M 180 3i 309 84 27 -ve -ve tt 
115 year s 
21 60 M 230 4 109 38 35 +ve +ve 
130 year s 
22 65 11.2 190 4 266 80 30 -ve -ve 
110 years 
23 60 M 200 4 
years 
323 88 27 -ve -ve " 
24 46 F 220 4 257 80 51 -ve -ve 2.2 -1018 Left Ventricular 
130 years 0.27m -1000 Hypertrophy 
25 45 M 200 5 250 90 36 -ve -ve " " 
120 years 
26 61 F 215 5 27 5 90 3 -ve -ve " If 
115 year s 
27 47 M 200 6 - 7 192 72 37 -ve -ve 2.3 -1018 
t' It 
110 years 0.43- -1000 
HYPE RTEed S I ON 
No, Age Sex Blood Duration CHOLESTEROL Liver Liver Kidney Electro- 
Pressure of mg, per 100 ml.of plasma Function Function cardio- 
mm Hg Illness Total Free Free Tests Tests graphic 
Total Cholesterol Changes 





















































































































No. Age SeY Blood Duration CIIOLESTEIIOL Liver Liver Kidney 
Pressure of mg»: 100 ml. of plasma Function Function 









H, 58 M 200 12 220 76 35 -ve -ve Inulin- Left Ven- 
170 years Diodrast tri cular 
Low Value Hypertrophy 
37 53 F 200 13 257 110 42 -ve -ve " it 't n 
120 years 
38 58 F 250 13 176 65 3R -ve -ve 21016 u tt 
130 years 0.2%-1000 
39 58 F 260 14 285 110 ° -ve -ve 2.86 -1024 " " 
L30 years 0.30 -1002 
40 60 F 260 14 136 57 42 -ve -ve 2.6iß -1020 " 
n 
140 years 0.4% -1002 
41 54 F 234 15 300 122 40 -ve -ve Inulin- " 
It 
150 years Diodrast 
Low Value 
42 66 F 216 15 164 72 44 -ve -ve 
It " " tt 
1t5 years 
43 62 Pi 270 15 140 55 50 +ve +ve " It 
35 years 
44 58 M 220 15 140 57 43 -ve -ve 
u 
25 years 
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